Novartis announces: Recruitment of the first ongoing clinical trial of Branaplam to treat spinal muscular atrophy is now closed

Already a few weeks ago.  Liz reported internally here. The recruitment of the first onging clinical trial to Branaplam  in spinal muscular atrophy is now closed – Novartis has officially announced this. It took 4.5 years to recruitment 44 babies with SMA type 1 in its first clinical trial of LMI070 (Branaplam), a breakthrough oral … Fortsätt läsa Novartis announces: Recruitment of the first ongoing clinical trial of Branaplam to treat spinal muscular atrophy is now closed